Business Context and Reporting Period
Company: Fluidigm Corporation (Note: Metadata lists "Standard BioTools Inc." but the filing text identifies the registrant as Fluidigm Corporation).
Filing Type: Form 8-K (Current Report).
Date of Report: January 14, 2020.
Reporting Period: Preliminary financial results for the fourth quarter and full year ended December 31, 2019.
Business Description: The registrant is a Delaware corporation with principal executive offices in South San Francisco, California. Its common stock trades on the Nasdaq Global Select Market under the symbol "FLDM".
Key Financial Metrics
The provided filing text serves as a cover document referencing a press release (Exhibit 99.1) containing the actual financial data. The text of the 8-K itself does not provide clear values for the following metrics:
- Revenue
- Profit (Net Income/Loss)
- Cash Flow
- Margins
- Debt
- Liquidity
Material Changes
The filing text does not contain specific numerical comparisons or descriptions of material changes versus the prior comparable period. It only indicates that preliminary results for Q4 and full-year 2019 were announced.
Guidance, Outlook, and Risks
Management Commentary: The filing references a press release issued on January 14, 2020, which contains the preliminary results and likely includes management commentary, but the content of that commentary is not included in the provided text.
Legal Status of Information: The information furnished in this report, including the attached press release, is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and shall not be incorporated by reference into other filings unless expressly stated.
Risks and Contingencies: No specific risks or contingencies are detailed in the provided text.
Investor Verification Checklist
- Verify the actual financial figures (Revenue, Net Loss, Cash Position) by reviewing Exhibit 99.1 (the Press Release dated January 14, 2020), as they are not present in the 8-K body text.
- Confirm the discrepancy between the metadata company name ("Standard BioTools Inc.") and the registrant name in the filing ("Fluidigm Corporation").
- Review the full press release for any forward-looking statements or guidance regarding 2020 operations.
- Check subsequent filings to see if the preliminary results were updated or if the company was acquired (Fluidigm was acquired by Standard BioTools in 2020, which may explain the metadata context).